# Pharmacokinetics and Pharmacodynamics of Long Acting Human Growth Hormone (hGH) Product (MOD-4023) in Healthy Caucasian and Japanese Volunteers

> **NCT02418767** · PHASE1 · COMPLETED · sponsor: **OPKO Health, Inc.** · enrollment: 42 (actual)

## Conditions studied

- Growth Hormone Deficiency

## Interventions

- **DRUG:** MOD-4023
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02418767
- **Lead sponsor:** OPKO Health, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01
- **Primary completion:** 2015-03
- **Final completion:** 2015-06
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2019-09-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02418767

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02418767, "Pharmacokinetics and Pharmacodynamics of Long Acting Human Growth Hormone (hGH) Product (MOD-4023) in Healthy Caucasian and Japanese Volunteers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02418767. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*